Ecolab Life Sciences Launches New Bioprocessing Purification Resin to Drive Manufacturing Productivity
Purolite™ AP+50 resin enables improved cost efficiencies in antibody manufacturing
“The ability to effectively improve process economics while maintaining purity is the gold standard of resin purification. As pharmaceutical and biotech companies seek to increase savings and improve business continuity, they are requiring innovative solutions to accelerate and de-risk manufacturing,” said Meeta Gulyani, senior vice president and general manager, Ecolab Bioprocessing. “Our resins are designed to help customers improve their product development platforms and implement next-generation manufacturing processes as well as enhance dual sourcing strategies that can reduce costs and bolster supply chains.”
Purolite AP+50 resin joins Ecolab’s full suite of purification resins including the recently launched Purolite DurA Cycle™ A50 for longer lifetimes and Purolite 70 CH1 which targets complex antibody fragments. Together, they support process intensification strategies and cost of goods reduction, which are critical in late-phase, large-scale manufacturing.
Ecolab’s newest innovation is being formally introduced at the 2025 BIO International Convention in
The announcement of Ecolab’s latest resin follows news of the opening of its newest Bioprocessing Applications Lab in
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of
Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.
(ECL-C)
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616402192/en/
Joseph Durrant
651-250-4724
MediaRelations@Ecolab.com
Source: Ecolab Life Sciences